{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:04:38Z","timestamp":1793117078444,"version":"4.5.0"},"update-to":[{"DOI":"10.1371\/journal.pmed.1003945","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T00:00:00Z","timestamp":1647388800000}}],"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T00:00:00Z","timestamp":1646179200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["NRF-2020R1C1C1003527"],"award-info":[{"award-number":["NRF-2020R1C1C1003527"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["NRF-2021R1A6A3A13046424"],"award-info":[{"award-number":["NRF-2021R1A6A3A13046424"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ministry of Food and Drug Safety of South Korea","award":["21153MFDS607"],"award-info":[{"award-number":["21153MFDS607"]}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Benzodiazepines are frequently prescribed during pregnancy; however, evidence about possible teratogenicity is equivocal. We aimed to evaluate the association between first-trimester benzodiazepine use and the risk of major congenital malformations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods and findings<\/jats:title>\n                    <jats:p>\n                      Using Korea\u2019s nationwide healthcare database, we conducted a population-based cohort study of women who gave birth during 2011 to 2018 and their live-born infants. The exposure was defined as one or more benzodiazepine prescriptions during the first trimester. We determined the relative risks (RRs) and confidence intervals (CIs) of overall congenital malformations and 12 types of organ-specific malformations. Infants were followed from birth to death or 31 December 2019, whichever came first (up to 8 years of age). Propensity score fine stratification was employed to control for 45 potential confounders. Among a total of 3,094,227 pregnancies, 40,846 (1.3%) were exposed to benzodiazepines during the first trimester (mean [SD] age, 32.4 [4.1] years). The absolute risk of overall malformations was 65.3 per 1,000 pregnancies exposed to benzodiazepines versus 51.4 per 1,000 unexposed pregnancies. The adjusted RR was 1.09 (95% CI 1.05 to 1.13,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001) for overall malformations and 1.15 (1.10 to 1.21,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001) for heart defects. Based on mean daily lorazepam-equivalent doses, the adjusted RRs for overall malformations and heart defects were 1.05 (0.99 to 1.12,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.077) and 1.12 (1.04 to 1.21,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.004) for &lt;1 mg\/day and 1.26 (1.17 to 1.36,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001) and 1.31 (1.19 to 1.45,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001) for &gt;2.5 mg\/day doses, respectively, suggesting a dose\u2013response relationship. A small but significant increase in risk for overall and heart defects was detected with several specific agents (range of adjusted RRs: 1.08 to 2.43). The findings were robust across all sensitivity analyses, and negative control analyses revealed a null association. Study limitations include possible exposure misclassification, residual confounding, and restriction to live births.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this large nationwide cohort study, we found that first-trimester benzodiazepine exposure was associated with a small increased risk of overall malformations and heart defects, particularly at the higher daily dose. The absolute risks and population attributable fractions were modest. The benefits of benzodiazepines for their major indications must be considered despite the potential risks; if their use is necessary, the lowest effective dosage should be prescribed to minimize the risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/clinicaltrials.gov\/\" xlink:type=\"simple\">ClinicalTrials.gov<\/jats:ext-link>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04856436\" xlink:type=\"simple\">NCT04856436<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pmed.1003945","type":"journal-article","created":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T13:59:46Z","timestamp":1646229586000},"page":"e1003945","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":52,"title":["First-trimester exposure to benzodiazepines and risk of congenital malformations in offspring: A population-based cohort study in South Korea"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3645-7358","authenticated-orcid":true,"given":"Yunha","family":"Noh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6556-9984","authenticated-orcid":true,"given":"Hyesung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0101-7328","authenticated-orcid":true,"given":"Ahhyung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1060-1462","authenticated-orcid":true,"given":"Jun Soo","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6270-5020","authenticated-orcid":true,"given":"Seung-Ah","family":"Choe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2634-1738","authenticated-orcid":true,"given":"Jungmi","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2372-1807","authenticated-orcid":true,"given":"Dong-Sook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1010-7525","authenticated-orcid":true,"given":"Ju-Young","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,3,2]]},"reference":[{"key":"pmed.1003945.ref001","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-3-642-54562-7_7","volume-title":"Psychopharmacology and Pregnancy","author":"S Gentile","year":"2014"},{"issue":"10","key":"pmed.1003945.ref002","doi-asserted-by":"crossref","first-page":"e1153","DOI":"10.4088\/JCP.14r09035","article-title":"Anxiety disorders during pregnancy: a systematic review","volume":"75","author":"JH Goodman","year":"2014","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"pmed.1003945.ref003","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ajog.2004.04.025","article-title":"Prescription drug use in pregnancy","volume":"191","author":"SE Andrade","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"pmed.1003945.ref004","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jad.2020.03.014","article-title":"Prevalence of benzodiazepines and benzodiazepine-related drugs exposure before, during and after pregnancy: A systematic review and meta-analysis","volume":"269","author":"B Bais","year":"2020","journal-title":"J Affect Disord"},{"key":"pmed.1003945.ref005","first-page":"1885","article-title":"Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice","volume":"11","author":"B Dell\u2019Osso","year":"2015","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"5","key":"pmed.1003945.ref006","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2165\/00003495-198223050-00002","article-title":"Use of benzodiazepines during pregnancy, labour and lactation, with particular reference to pharmacokinetic considerations.","volume":"23","author":"JH Kanto","year":"1982","journal-title":"Drugs"},{"issue":"6","key":"pmed.1003945.ref007","first-page":"375","article-title":"Accumulation of diazepam and N-demethyldiazepam in the fetal blood during the labour","volume":"5","author":"J Kanto","year":"1973","journal-title":"Ann Clin Res"},{"issue":"1","key":"pmed.1003945.ref008","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/jcp.10391","article-title":"Effects of peripheral benzodiazepine receptor ligands on proliferation and differentiation of human mesenchymal stem cells","volume":"198","author":"DH Lee","year":"2004","journal-title":"J Cell Physiol"},{"key":"pmed.1003945.ref009","volume-title":"Antenatal and postnatal mental health: clinical management and service guidance","author":"National Institute for Health and Care Excellence: Clinical Guidelines","year":"2014"},{"issue":"233","key":"pmed.1003945.ref010","first-page":"72063","article-title":"Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling","volume":"79","year":"2014","journal-title":"Final rule. Fed Regist"},{"issue":"4","key":"pmed.1003945.ref011","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.18r12412","article-title":"Benzodiazepine Use During Pregnancy Alone or in Combination With an Antidepressant and Congenital Malformations: Systematic Review and Meta-Analysis","volume":"80","author":"S Grigoriadis","year":"2019","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"pmed.1003945.ref012","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S1701-2163(16)34772-7","article-title":"The fetal safety of benzodiazepines: an updated meta-analysis","volume":"33","author":"E Enato","year":"2011","journal-title":"J Obstet Gynaecol Can"},{"key":"pmed.1003945.ref013","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/978-3-319-92919-4_11","volume-title":"Perinatal Psychopharmacology","author":"C Bellantuono","year":"2019"},{"issue":"1","key":"pmed.1003945.ref014","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.genhosppsych.2012.09.003","article-title":"Benzodiazepine exposure in pregnancy and risk of major malformations: a critical overview","volume":"35","author":"C Bellantuono","year":"2013","journal-title":"Gen Hosp Psychiatry"},{"issue":"7162","key":"pmed.1003945.ref015","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/bmj.317.7162.839","article-title":"Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies","volume":"317","author":"LR Dolovich","year":"1998","journal-title":"BMJ"},{"issue":"1","key":"pmed.1003945.ref016","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1176\/appi.ps.53.1.39","article-title":"Effects of commonly used benzodiazepines on the fetus, the neonate, and the nursing infant.","volume":"53","author":"MM Iqbal","year":"2002","journal-title":"Psychiatr Serv."},{"issue":"6","key":"pmed.1003945.ref017","first-page":"553","article-title":"In utero exposure to benzodiazepine. Is there a risk for anal atresia with lorazepam?","volume":"29","author":"O Bonnot","year":"2003","journal-title":"Enc\u00e9phale"},{"issue":"11","key":"pmed.1003945.ref018","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/pds.1457","article-title":"Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations","volume":"16","author":"BN Wikner","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"10","key":"pmed.1003945.ref019","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3390\/ph6101221","article-title":"The use of central nervous system active drugs during pregnancy.","volume":"6","author":"B K\u00e4ll\u00e9n","year":"2013","journal-title":"Pharmaceuticals (Basel)"},{"issue":"6","key":"pmed.1003945.ref020","doi-asserted-by":"crossref","first-page":"e100996","DOI":"10.1371\/journal.pone.0100996","article-title":"First trimester exposure to anxiolytic and hypnotic drugs and the risks of major congenital anomalies: a United Kingdom population-based cohort study","volume":"9","author":"L Ban","year":"2014","journal-title":"PLoS ONE"},{"issue":"4","key":"pmed.1003945.ref021","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000139363","article-title":"Benzodiazepine side effects: role of pharmacokinetics and pharmacodynamics","volume":"51","author":"AN Vgontzas","year":"1995","journal-title":"Pharmacology"},{"key":"pmed.1003945.ref022","volume-title":"Report of the evaluation for validity of discharged diagnoses in Korean Health Insurance database","author":"E Park","year":"2017"},{"issue":"1","key":"pmed.1003945.ref023","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/pds.3284","article-title":"Algorithms to estimate the beginning of pregnancy in administrative databases","volume":"22","author":"AV Margulis","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"pmed.1003945.ref024","volume-title":"Drugs during pregnancy and lactation: treatment options and risk assessment","author":"C Schaefer","year":"2014"},{"key":"pmed.1003945.ref025","unstructured":"Drug and Alcohol Services South Australia. Benzodiazepines: Information for GPs. In: Australia GoS, editor. Updated: 14 Mar 2021."},{"key":"pmed.1003945.ref026","author":"HC Ashton","year":"2007","journal-title":"Benzodiazepine equivalence table"},{"key":"pmed.1003945.ref027","unstructured":"EUROCAT. EUROCAT Guide 1.4: Instruction for the registration of congenital anomalies. EUROCAT Central Registry, University of Ulster; 2013."},{"issue":"5","key":"pmed.1003945.ref028","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/AOG.0b013e3182a603bb","article-title":"Development of a comorbidity index for use in obstetric patients","volume":"122","author":"BT Bateman","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"13","key":"pmed.1003945.ref029","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1111\/1471-0528.13254","article-title":"Validation of an obstetric comorbidity index in an external population","volume":"122","author":"A Metcalfe","year":"2015","journal-title":"BJOG"},{"key":"pmed.1003945.ref030","doi-asserted-by":"crossref","first-page":"k757","DOI":"10.1136\/bmj.k757","article-title":"Population attributable fraction","volume":"360","author":"MA Mansournia","year":"2018","journal-title":"BMJ"},{"issue":"1","key":"pmed.1003945.ref031","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12940-019-0492-4","article-title":"Estimation and application of population attributable fraction in ecological studies.","volume":"18","author":"CK Lin","year":"2019","journal-title":"Environ Health."},{"issue":"2","key":"pmed.1003945.ref032","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/EDE.0000000000000595","article-title":"A Propensity-score-based Fine Stratification Approach for Confounding Adjustment When Exposure Is Infrequent.","volume":"28","author":"RJ Desai","year":"2017","journal-title":"Epidemiology"},{"issue":"9","key":"pmed.1003945.ref033","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1001\/jamapsychiatry.2019.0963","article-title":"Association Between Incident Exposure to Benzodiazepines in Early Pregnancy and Risk of Spontaneous Abortion","volume":"76","author":"O Sheehy","year":"2019","journal-title":"JAMA Psychiat"},{"issue":"1","key":"pmed.1003945.ref034","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/ije\/4.1.37","article-title":"Associations between oral clefts and drugs taken during pregnancy","volume":"4","author":"I. Sax\u00e9n","year":"1975","journal-title":"Int J Epidemiol"},{"issue":"7933","key":"pmed.1003945.ref035","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0140-6736(75)90548-6","article-title":"Association between cleft lip with or without cleft palate and prenatal exposure to diazepam","volume":"2","author":"MJ Safra","year":"1975","journal-title":"Lancet"},{"issue":"21","key":"pmed.1003945.ref036","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1056\/NEJM198311243092103","article-title":"Lack of relation of oral clefts to diazepam use during pregnancy","volume":"309","author":"L Rosenberg","year":"1983","journal-title":"N Engl J Med"},{"key":"pmed.1003945.ref037","unstructured":"World Health Organisation (WHO) Collaborating Centre for Drug Statistics Methodology. The anatomical therapeutic chemical (ATC) classification system and defined daily dose (DDD) index 2021. Available from: https:\/\/www.whocc.no\/atc_ddd_index\/."},{"issue":"5","key":"pmed.1003945.ref038","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/cpt1975175564","article-title":"Placental transfer to diazepam and its disposition in the newborn","volume":"17","author":"M Mandelli","year":"1975","journal-title":"Clin Pharmacol Ther"},{"issue":"17","key":"pmed.1003945.ref039","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1001\/jama.2016.16435","article-title":"Confounding by Indication in Clinical Research","volume":"316","author":"DN Kyriacou","year":"2016","journal-title":"JAMA"}],"updated-by":[{"DOI":"10.1371\/journal.pmed.1003945","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T00:00:00Z","timestamp":1647388800000}}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1003945","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T01:52:39Z","timestamp":1674870759000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1003945"}},"subtitle":[],"editor":[{"given":"Sarah J.","family":"Stock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,3,2]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1003945","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,2]]}}}